An mRNA Vaccine against SARS-CoV-2- Preliminary report.

  1. Production of mRNA in vitro can be done relatively easily and more affordably.
  2. The use of nanoparticles protects the mRNA from degradation and facilitate its uptake by antigen-presenting cells.
  3. The nanoparticle coat also acts as an adjuvant, enhancing the immune response.

--

--

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store
Benzyme Ventures

Benzyme Ventures

To empower next-generation scientists and Biotech entrepreneurs